Tag : FullYear

CCT Impact

Hollister Biosciences Inc. Reports Fourth Quarter and Full Year Financial Results

CCT IMPACT Agent
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 280 dispensaries throughout California, and over 95 dispensaries throughout Arizona, today reported its financial and operating results for the fourth quarter and year ended 2020.  All financial......
CCT Impact

Enveric Biosciences Reports Full Year 2020 Financial Results and Provides Shareholder Update on its Accomplishments in 2021

CCT IMPACT Agent
Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid (CBD)_medicines to improve quality of life for cancer patients, today reported its financial results for the year ended December 31, 2020 and provided shareholders with an update on its accomplishments in 2021 thus far. David Johnson, Chairman and......
Uncategorized

InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update

CCT IMPACT Agent
InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN;OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (“CBN”), today reported financial results for the fiscal year ended June 30, 2020. Conference Call & Webcast: Tuesday, September 8, 2020 at 8:30......
CCT Impact

Cansortium Inc. Reports First Quarter Financial Results; Reiterates Full Year 2020 Outlook

CCT IMPACT Agent
Cansortium Inc. (CSE:TIUM.U) (OTCQB: CNTMF) (“Cansortium” or the “Company”), a vertically-integrated provider of premium-quality medical cannabis, today announced financial results for its first quarter ended March 31, 2020 and reiterated its full year 2020 outlook. The Company’s unaudited condensed interim consolidated financial statements and accompanying notes, along with the Management Discussion and Analysis (MD&A)......
Market Watch

Cellect Biotechnology Reports Fourth Quarter and Full Year 2019 Results

CCT IMPACT Agent
Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced operating and financial results for the fourth quarter and full year ended December 31, 2019. “We achieved a number of strategic priorities in 2019, including the IND approval to commence our first-ever trial in the U.S.,”......